| Financial Year |
March 31 2023 |
| Monetary Funds |
62,894,741.08 |
| Held-for-trading Financial Assets |
326,885.12 |
| Notes Receivable |
5,553,509.00 |
| Accounts Receivable |
206,177,198.80 |
| Advances to Suppliers |
10,094,782.28 |
| Other Receivables |
1,633,035.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
166,560,048.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,478,433.08 |
| Total Current Assets |
459,540,465.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,737,814.59 |
| Investment Properties |
-- |
| Fixed Assetes |
161,138,715.66 |
| Under-construction Projects |
19,410,198.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,397,135.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,104,236.50 |
| Deferred Income Tax Assets |
9,822,272.88 |
| Other Non-Current Assets |
46,027,168.62 |
| Sub-Total of Non-Current Assets |
359,761,470.03 |
| Total Assets |
819,301,935.78 |
| Short-Term Loans |
69,551,425.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,231,628.13 |
| Accounts Payable |
68,325,706.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,826,434.96 |
| Taxes Payable |
4,818,404.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,148,253.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,815,641.17 |
| Other Current Liabilities |
2,723,853.44 |
| Sub-Total of Current Liabilities |
199,549,234.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,358,907.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,643,560.12 |
| Total Liabilities |
214,192,795.06 |
| Paid-In Capital(Or Share Stock) |
140,128,700.00 |
| Capital Surplus |
94,545,141.83 |
| Surplus Reserve |
39,469,895.76 |
| LESS:Treasury Stock |
29,162,931.62 |
| Undistributed Profits |
347,445,660.83 |
| Minority Stockholder's Interest |
4,982,200.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
600,126,940.65 |
| Owner's Equity（Stockholder's Equity） |
605,109,140.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
819,301,935.78 |
